Suppr超能文献

[铊-201闪烁扫描术在骨肉瘤新辅助化疗评估中的价值]

[Value of thallium-201 scintigraphy in assessment of neoadjuvant chemotherapy for osteosarcoma].

作者信息

Huang Zhong-ke, Lou Cen, Fang Xiang-qian

机构信息

Department of Nuclear Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou 310016, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2009 Oct;31(10):769-72.

Abstract

OBJECTIVE

To investigate the significance of Tl-201 scintigraphy for assessment of neoadjuvant chemotherapy for osteosarcoma.

METHODS

Thirty-four cases with osteosarcoma were enrolled into this study. The Tl-201 scintigraphy features including uptake ratio(UR) and size ratio(SR) were obtained in both early and delay imaging stages before and after chemotherapy. The responses of chemotherapy were classified into three grades according to the percentage of tumor necrosis in the specimens: necrosis < 50% as grade 1, necrosis of 50% approximately 90% as grade 2, diffuse necrosis > 90% as grade 3. The alteration ratio (AR) and SR were calculated according to tumor necrosis ratio (TNR).

RESULTS

Of the 6 patients with grade 1 response, the mean alteration ratios were 3.19% +/- 8.40% and -26.29% +/- 63.61% in early and delay imaging stages, respectively. Among the 18 patients with grade 2 response, the mean alteration ratios were 40.07% +/- 11.95% and 39.30% +/- 9.87%, respectively. Of the 10 patients with grade 3 response, the mean alteration ratios were 78.32% +/- 8.33% and 63.26% +/- 6.06% in early and delay imaging stages, respectively. The results of liner regression analysis of TNR of the surgical specimens showed a significantly positive correlation (r = 0.71) between AR and TNR. The lesion size was reduced in 18 cases, but unchanged in 8 and increased in 8. The liner regression analysis results showed a negative correlation between SR and TNR.

CONCLUSION

The alteration ratio changes significantly after neoadjuvant chemotherapy and has a significantly positive correlation with tumor necrosis ratio. Thallium-201 scintigraphy is helpful in the evaluation of neoadjuvant chemotherapy for osteosarcoma.

摘要

目的

探讨铊-201闪烁扫描术在评估骨肉瘤新辅助化疗中的意义。

方法

34例骨肉瘤患者纳入本研究。在化疗前后的早期和延迟显像阶段获取铊-201闪烁扫描特征,包括摄取率(UR)和大小比(SR)。根据标本中肿瘤坏死百分比将化疗反应分为三个等级:坏死<50%为1级,坏死50%至90%为2级,弥漫性坏死>90%为3级。根据肿瘤坏死率(TNR)计算变化率(AR)和SR。

结果

6例1级反应患者中,早期和延迟显像阶段的平均变化率分别为3.19%±8.40%和-26.29%±63.61%。18例2级反应患者中,平均变化率分别为40.07%±11.95%和39.30%±9.87%。10例3级反应患者中,早期和延迟显像阶段的平均变化率分别为78.32%±8.33%和63.26%±6.06%。手术标本TNR的线性回归分析结果显示AR与TNR之间存在显著正相关(r = 0.71)。18例病变大小缩小,8例不变,8例增大。线性回归分析结果显示SR与TNR之间存在负相关。

结论

新辅助化疗后变化率有显著改变,且与肿瘤坏死率呈显著正相关。铊-201闪烁扫描术有助于评估骨肉瘤的新辅助化疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验